Blue Owl Capital Holdings »

Aspire Biopharma Hldgs Inc Wt Exp 021430 shares owned by Blue Owl Capital Holdings

Quarter-by-quarter ownership of Aspire Biopharma Hldgs Inc Wt Exp 021430 (ASBPW) shares owned by Blue Owl Capital Holdings from 13F filings

Historical chart of Blue Owl Capital Holdings investment in Aspire Biopharma Hldgs Inc Wt Exp 021430

Tip: Access up to 7 years of quarterly data

All positions including Aspire Biopharma Hldgs Inc Wt Exp 021430 held by Blue Owl Capital Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aspire Biopharma Hldgs Inc Wt Exp 021430 by Blue Owl Capital Holdings

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.5k 50k 0.03
2025-06-30 $2.2k 50k 0.04
2025-03-31 $3.5k 50k 0.07

More positions owned by Blue Owl Capital Holdings

Nuveen Churchill Direct Lend Com Shs (NCDL)
Owl Rock Capital Corporation (OBDC)
Engene Holdings (ENGN)
Larimar Therapeutics (LRMR)
Evercommerce (EVCM)
Holley (HLLY)
Roivant Sciences SHS (ROIV)
Cullinan Oncology (CGEM)
Ultragenyx Pharmaceutical (RARE)
Conduent Incorporate (CNDT)
Sagimet Biosciences Com Ser A (SGMT)
Compass Therapeutics (CMPX)
Dell Technologies CL C (DELL)
Civeo Corp Cda Com New (CVEO)
Context Therapeutics (CNTX)

View all positions for Blue Owl Capital Holdings

Top funds holding Aspire Biopharma Hldgs Inc Wt Exp 021430

Adage Capital Partners GP
Saba Capital Management
Linden Advisors
Aristeia Capital
Highbridge Capital Management
Toronto-Dominion Bank
OZ Management
Verition Fund Management
Barclays
Clear Street
Millennium Management
Alberta Investment Management Corporation
Antara Capital
D. E. Shaw & Co
Wolverine Asset Management

View all funds holding Aspire Biopharma Hldgs Inc Wt Exp 021430